pomegranate seed oil study

INTERVENTION: Intervention 1: Pomegranate seed oil capsule, containing 400 mg PSO, twice daily (800 mg PSO) for 4 weeks. Intervention 2: Placebo capsule. Placebo Placebo capsule Pomegranate seed oil capsule, containing 400 mg PSO, twice daily (800 mg PSO) for 4 weeks Treatment ‐ Drugs CONDITION: Disorders of lipoprotein metabolism and other lipidaemias hyperlipidemia. ; Disorders of lipoprotein metabolism and other lipidaemias PRIMARY OUTCOME: Lipid profile concentration. Timepoint: 1 month. Method of measurement: biochemical measurements on blood sample. SECONDARY OUTCOME: Hyperlipidemia. Timepoint: 1 month. Method of measurement: biochemical measurements on blood sample. INCLUSION CRITERIA: INCLUSION CRITERIA: serum cholesterol concentrations > 200 mg/dl , serum triglyceride concentration > 150 mg/dl, age more than 20 years, body mass index = 35 kg/m2 Exclusion criteria: being pregnant or lactating, diagnosed allergy and liver dysfunction